The relationship between serum asymmetric dimethylarginine levels and radial artery spasm

Özet

Objective: The use of the radial approach in coronary angiography or percutaneous coronary intervention has increased owing to its advantagesover the femoral approach such as rapid patient mobilization and improved patient comfort. However, radial artery spasm (RAS) that occurs during the procedure is a crucial factor in transradial approach failure and access site switch. Asymmetric dimethylarginine (ADMA) is a naturallyoccurring, modified amino acid that inhibits nitric oxide (NO) production. High ADMA levels may reduce arterial elasticity especially in smallarteries like the radial artery. This study aimed to evaluate the relationship between ADMA levels and RAS in radial artery access.Methods: This study included 155 patients (89 males and 66 females) who underwent transradial coronary angiography between January 2016and June 2016. The ADMA level in the plasma was determined using a quantitative sandwich enzyme immunoassay technique.Results: RAS was observed in 16 of the 155 patients (10.1%). The RAS was found to be more frequent in female patients (17.9% for women vs.4.4% for men, p=0.019). The plasma concentration of ADMA in the RAS group was significantly higher than that in the control group [22.1 ng/mL(12.1–37.8) vs. 9.2 ng/mL (5.9–14.8), p<0.001]. Moreover, the plasma concentration of ADMA was significantly higher in patients with RAS amongfemale patients [20.4 ng/mL (12.1–44.9) vs. 9.9 ng/mL (6.2–16.6); p=0.002] and among male patients [25.2 ng/mL (13.7–35.4) vs. 8.2 ng/mL (5.9–12.8);p=0.007]. Binary logistic regression analysis of all patients showed that ADMA concentration was the only predictor for RAS (odds ratio=1.142;95% confidence interval=1.061–1.228; p<0.001).Conclusion: It was found that the ADMA concentration of the patients in the RAS group was elevated compared to that of controls. The findingsindicated that elevated ADMA concentrations could predict RAS that may occur. (Anatol J Cardiol 2020; 23: 228-32)